Pathologic Significance and Prognostic Value of Phosphorylated Cortactin Expression in Patients With Sarcomatoid Renal Cell Carcinoma

Our results have demonstrated that phosphorylation of cortactin is a key process in malignant aggressiveness, and its expression is a useful predictor of cause-specific survival and could be a useful potential therapeutic target in patients with SRCC.